All lobbying filings
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. filed a Q2 report for Madrigal Pharmaceuticals, Inc. on July 20, 2026.
Lobbying for Madrigal Pharmaceuticals, Inc. · Biopharmaceutical company
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Expenses
$380,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Pennsylvania
Government bodies contacted
2
Lobbying activity
2
Issues related to CMMI drug pricing; 340B drug pricing
Most Favored Nation drug pricing; Issues related to CMMI drug pricing